We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Matrix Service
MTRX
$312M
| $183K | ﹤0.01% |
+13,550
| New | +$164K |
|
1477
GrowGeneration
GRWG
$84.7M
| $182K | ﹤0.01% |
+194,210
| New | +$207K |
|
1478
Fractyl Health
GUTS
$109M
| $181K | ﹤0.01% |
+111,425
| New | +$180K |
|
1479
TAL Education Group
TAL
$6.04B
| $180K | ﹤0.01% |
17,646
+2,607
| +17% | +$26.9K |
|
1480
Bioventus
BVS
$889M
| $179K | ﹤0.01% |
+27,074
| New | +$192K |
|
1481
Capitol Federal Financial
CFFN
$1.09B
| $178K | ﹤0.01% |
+29,160
| New | +$165K |
|
1482
B&G Foods
BGS
$303M
| $178K | ﹤0.01% |
+42,020
| New | +$219K |
|
|
ETNB
1483
DELISTED
89bio
ETNB
| $176K | ﹤0.01% |
+17,876
| New | +$148K |
|
1484
Caribou Biosciences
CRBU
$146M
| $173K | ﹤0.01% |
+137,211
| New | +$135K |
|
1485
Viridian Therapeutics
VRDN
$2.2B
| $170K | ﹤0.01% |
+12,180
| New | +$165K |
|
|
ZH
1486
Zhihu
ZH
$287M
| $169K | ﹤0.01% |
+42,431
| New | +$165K |
|
|
DEC
1487
Diversified Energy Company
DEC
$902M
| $168K | ﹤0.01% |
+11,451
| New | +$153K |
|
1488
Bausch Health
BHC
$1.75B
| $165K | ﹤0.01% |
+24,761
| New | +$127K |
|
1489
Nautilus Biotechnolgy
NAUT
$132M
| $163K | ﹤0.01% |
+224,456
| New | +$169K |
|
1490
Roadzen
RDZN
$98.1M
| $159K | ﹤0.01% |
+162,032
| New | +$162K |
|
|
CLYM
1491
Climb Bio
CLYM
$693M
| $159K | ﹤0.01% |
+127,952
| New | +$159K |
|
1492
Eton Pharmaceutcials
ETON
$1.32B
| $157K | ﹤0.01% |
10,991
-2,409
| -18% | -$38.1K |
|
1493
Energy Vault
NRGV
$455M
| $156K | ﹤0.01% |
+218,182
| New | +$176K |
|
1494
Quest Resource Holding
QRHC
$27.6M
| $156K | ﹤0.01% |
+77,187
| New | +$177K |
|
1495
New Mountain Finance
NMFC
$654M
| $156K | ﹤0.01% |
14,772
-42,324
| -74% | -$436K |
|
1496
Ramaco Resources Class B
METCB
$423M
| $152K | ﹤0.01% |
+19,582
| New | +$146K |
|
1497
PagSeguro Digital
PAGS
$2.67B
| $151K | ﹤0.01% |
15,623
+2,904
| +23% | +$26.2K |
|
1498
QuickLogic
QUIK
$211M
| $149K | ﹤0.01% |
+24,138
| New | +$133K |
|
|
VTYX
1499
DELISTED
Ventyx Biosciences
VTYX
| $148K | ﹤0.01% |
+69,236
| New | +$112K |
|
1500
NewtekOne
NEWT
$426M
| $148K | ﹤0.01% |
13,081
-7,309
| -36% | -$78.1K |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.